Press Releases Nicox SA

Equities

ALCOX

FR0013018124

Market Closed - Euronext Paris Other stock markets 09:05:13 02/05/2024 pm IST			5-day change	1st Jan Change
0.387 ^EUR	-1.28%		+2.11%	-12.44%

22/04	Nicox: cash position of 9.1 million euros at the end of March	CF
28/02	Nicox, BlackRock Sign Deal for Debt Restructuring	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nicox, Second notice of the Ordinary and Extraordinary Shareholders Meeting on May 6, 2024 and appointment of an ad hoc agent	25/04	AQ
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent	24/04	GL
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent	24/04	AQ
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results	22/04	GL
Nicox, 2024 Ordinary and Extraordinary Shareholder Meeting	10/04	AQ
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting	09/04	GL
Nicox : Shareholder Letter	22/03	PU
Nicox's Shareholder Letter	22/03	GL
Nicox's Shareholder Letter	22/03	AQ
Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of Ophthalmology	20/03	GL
Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of Ophthalmology	20/03	AQ
Nicox to Hold Webcast on March 18 on its Corporate Pipeline and Financing Perspectives and Key NCX 470 Clinical Data with Presentation by Leading French Glaucoma Key Opinion Leader	15/03	AQ
Nicox : How to participate in the general meeting	13/03	PU
Nicox Updates on Corporate, Pipeline and Financing Perspectives and Will Hold a Webcast on March 18, 2024	13/03	GL
Nicox Updates on Corporate, Pipeline and Financing Perspectives and Will Hold a Webcast on March 18, 2024	13/03	AQ
Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual Meeting	05/03	GL
Nicox : Nombre de droits de vote au 29 février 2024	01/03	PU
Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal Trial	28/02	GL
Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO	28/02	GL
Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japan	08/02	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nicox SA

Equities

ALCOX

FR0013018124

Press Releases

Filters